Business Standard

Oxygenta Pharmaceutical Ltd Announcements

BY EXCHANGE :

ANNOUNCEMENTSUBJECTATTACHMENTBROADCAST DATE
Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of SEBI (LODR) Regulations 2015 And All Other Applicable Regulations. Oxygenta Pharmaceutical Ltdhas informed BSE that the meeting of the Board of Dir...Read More23/05/2024
Announcement under Regulation 30 (LODR)-Allotment We wish to inform you that Allotment committee of the Board of Directors allotte...Read More21/05/2024
Shareholders Meeting/ Postal Ballot - Voting Results We hereby submit the Voting results of the EGM held on May 092024.10/05/2024
Shareholder Meeting / Postal Ballot-Scrutinizers Report We hereby submit the consolidated report of Scrutinizer10/05/2024
Compliance Certificate Under Regulation 7(3) Of The SEBI (Listing Obligations And Disclosures Requirements) Regulations 2015 For The Financial Year Ended 31St March 2024. Please find the enclosed Compliance Certificate under Regulation 7(3) of the SEB...Read More26/04/2024
Compliance Certificate Under Reg.40 (9) Of SEBI (LODR) Regulations 2015 For The Financial Year Ended 31St March 2024. We are enclosing the certificate issued by CS N Vanitha Practicing company Secre...Read More25/04/2024
Draft Letter of Offer Mark Corporate Advisors Pvt Ltd (Manager to the Offer) has submitted to BSE a co...Read More25/04/2024
Detailed Public Statement Mark Corporate Advisors Pvt Ltd (Manager to the Offer) has submitted to BSE a co...Read More18/04/2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 With reference to the above we are enclosing the certificate dated 03.04.2024 is...Read More15/04/2024
Notice Of Extra-Ordinary General Meeting Of The Company We would like to inform you that the Extra-Ordinary General Meeting (EGM) of the...Read More13/04/2024
Open Offer Mark Corporate Advisors Pvt Ltd. (Manager to the Offer) has submitted to BSE a c...Read More08/04/2024
Board Meeting Outcome for Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (Listing Regulations) Pursuant to Regulation 30 read with Part A of Schedule III of the Listing Regula...Read More08/04/2024
Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of SEBI (LODR) Regulations 2015 And All Other Applicable Regulations. Oxygenta Pharmaceutical Ltdhas informed BSE that the meeting of the Board of Dir...Read More03/04/2024
Closure of Trading Window Closure of trading window from April 012024 till 48 hours from the declaration o...Read More30/03/2024
Clarification On Intimation Of Appointment Of Company Secretary And Compliance Officer. We are giving clarification for the mail received from exchange on 23rd march 20...Read More26/03/2024
Outcome Of Board Meeting Under Regulation 30 And Other Applicable Provisions Of SEBI (Listing Obligations And Disclosure Requirements) Regulation 2015. Re-appointment of Mrs. Padmaja Surapureddy (DIN: 05358127) as Non-executive Inde...Read More04/03/2024
Board Meeting Outcome for Outcome Of Board Meeting Under Regulation 30 And Other Applicable Provisions Of SEBI (Listing Obligations And Disclosure Requirements) Regulation 2015. To Re-appointment of Mrs. Padmaja Surapureddy (DIN: 05358127) as Non-Executive I...Read More04/03/2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Duplicate share certificate request received from the shareholder22/02/2024
Announcement under Regulation 30 (LODR)-Newspaper Publication News paper publication of Q3 results.16/02/2024
Revised Un-Audited Financial Results Under Regulation 30 And 33 Of SEBI (LODR) Regulations 2015. We are submitting the revised un audited results for the Quarter ended on 31st D...Read More14/02/2024

Load more